🇺🇸 FDA
Pipeline program

[68Ga]Ga-PentixaFor, FLUDEOXYGLUCOSE (18F)

PTF301

Phase 3 small_molecule active

Quick answer

[68Ga]Ga-PentixaFor, FLUDEOXYGLUCOSE (18F) for Marginal Zone Lymphoma is a Phase 3 program (small_molecule) at Pharm Research Associates (UK) Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharm Research Associates (UK) Limited
Indication
Marginal Zone Lymphoma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials